Capital Health Cancer Center Approved as a Participating National Cancer Institute Community Oncology Research Program Site | Ca

Capital Health Cancer Center Approved as a Participating National Cancer Institute Community Oncology Research Program Site | Capital Health Hospitals
Capital Health Cancer Center Approved as a Participating National Cancer Institute Community Oncology Research Program Site
Tuesday, April 11, 2023
Capital Health Medical Center – Hopewell is now an NCI Community Oncology Research Program (NCORP) affiliate site of the Atlantic Health Cancer Consortium (AHCC). As a participating site,
Capital Health Cancer Center
will now offer residents in the greater Mercer and Bucks County region access to new and innovative NCI-sponsored clinical trials in the cancer prevention and control, screening, care delivery, and treatment areas.
“The vision for our Cancer Center is clear,” said Al Maghazehe, President and CEO of Capital Health, “To deliver exceptional care for our patients in a convenient location, with the clinical and support services they need and the research to support their fight and the advancement of care. Our participation in NCORP brings more opportunities to our patients, who are at the heart of everything we do.”
“Capital Health is known for its commitment to providing people of the greater Mercer and Bucks County regions with the highest quality care close to home,” said
Dr. Cataldo Doria, medical director of Capital Health Cancer Center
. “With the NCORP site designation, our Cancer Center will provide patients access to cancer clinical trials and cancer care delivery studies that are available at top institutions around the nation. We look forward to contributing to NCORP’s national network of research that focuses on cancer prevention, screening, and treatment, especially in regard to how it affects access to care among underserved populations. This aligns well with Capital Health’s mission to serve urban and suburban communities in our area.”
“Academic medical centers play an important part in cancer research, but most cancer care is provided in local communities,” said Dr. Doria. “By expanding research outside academic settings as an AHCC NCORP site, we will provide access to a larger patient population that is more diverse and better reflects the complexity of cancer care.”
As part of AHCC NCORP, Capital Health Cancer Center’s team of providers and researchers will help patients gain access to clinical trials across a broad range of cancer care benchmarks, including symptom management, prevention, screening, surveillance, care delivery and quality of life. The NCORP network's diversity in patient age, race, and geographic location, provides a natural laboratory for developing improved strategies for cancer prevention, more efficient cancer trials, and a better balance between the risks and benefits of interventions.
“On behalf of the entire organization, I am excited to welcome Capital Health Medical Center – Hopewell to Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP), the only New Jersey-based NCI Community Oncology Research Program (NCORP),” said Dr. Eric Whitman, principal investigator at AHCC CORP and medical director of Atlantic Health System Cancer Care. “Together we will continue to advance the science of cancer care and shine new lights on cancer journey pathways for our patients.”
To help connect patients to advanced care options, research staff at Capital Health Cancer Center will select trials from the NCORP research portfolio that may benefit the Center’s patient population. Appropriate studies are then presented to oncology physician teams to determine if they are good fits for specific patients. When a match is made, a primary investigator is appointed, and Capital Health research staff open the trial for Capital Health Cancer Center patients.
To learn more about open clinical trials at Capital Health Cancer Center, visit
www.capitalhealthcancer.org/ncorp
to sign-up for email updates or call 609-537-6363 to schedule a consultation with one of our physicians.
About Capital Health Cancer Center
Capital Health Cancer Center is the area’s most advanced provider of cancer treatment delivered by some of the most experienced medical experts. At the Center,
a team of physicians
from related fields such as medical oncology, radiation oncology, gynecological oncology, neurosurgery, hepato-pancreato-biliary surgery, colorectal surgery, interventional GI and pulmonology, radiology, plastic and reconstructive surgery, thoracic surgery and other specialties collaborate and provide patients with a network of physicians trained in the most complex oncology issues. Capital Health is the only center in the region that offers advanced treatment options such as
CyberKnife® Radiosurgery
da Vinci® Robotic-Assisted Surgery
TrueBeam® Linear Accelerator
(traditional 3D conformal radiation therapy, intensity modulated radiation therapy, RapidArc® radiotherapy, and stereotactic radiosurgery), high-dose-rate radiation therapy, volumetric modulated arc therapy, advanced imaging technology (digital mammography, 3D mammography, molecular breast imaging, PET/CT, and 3T MRI), nuclear isotopes (SIR-spheres), and more. Visit
capitalhealthcancer.org
to learn more.
About AHCC NCORP
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP) is the first and only New Jersey-based National Cancer Institute (NCI) Community Oncology Research Program (NCORP). Combining the collective strengths of world-class healthcare systems with community oncology care delivery, the consortium includes Atlantic Health System, Capital Health, CentraState Healthcare System, Holy Name Medical Center, Hunterdon Healthcare and Saint Peter’s Healthcare System. Atlantic Health System will serve as the lead affiliate for NCORP Community Site activities, providing the scientific leadership and central support personnel necessary to accomplish the AHCC NCORP objectives. Atlantic Health System leadership includes experienced cancer investigators in both adult and pediatric cancers with unique expertise that span the cancer continuum. The overall goals of the consortium are to improve and extend the lives of New Jerseyans with cancer and reduce disparities by providing access to leading edge clinical trials in community settings. The consortium covers nearly three-quarters of the state and 6.5 million people.
NCORP is a grant funded, community-based cancer research network of the National Cancer Institute with sites throughout the country. The network designs and conducts clinical trials and other cancer studies involving adults and children. These studies focus on cancer control, prevention, screening and care delivery, as well as quality-of-life research embedded within the treatment clinical trials. NCORP and its sites incorporate the needs of diverse populations such as children, adolescents and young adults; the elderly; racial and ethnic minorities; sexual and gender minorities; and rural residents into studies and take steps to enhance participation of these groups. NCORP also enhances patient and provider access to treatment and imaging trials conducted under NCI’s National Clinical Trials Network. In addition, NCORP integrates cancer disparities research within the community research network.
Latest News
Upcoming Events
Capital Health Opens OB/GYN Office in Princeton
Capital Health OB/GYN, a comprehensive women’s health practice that is part of Capital Health Medical Group, is pleased to announce the opening of Capital Health OB/GYN – Princeton. This new office is located in the space previously occupied by Women’s Healthcare of Princeton at 800 Bunn Drive, Suite 202, in Princeton, New Jersey.
New Support Program at Capital Health Helps Women Navigate Healing and Intimacy After Cancer Treatment
For women who have received treatment for breast cancer, gynecologic cancers, colorectal cancer and others that may affect hormonal balance, pelvic function, or sexual health, Capital Health Cancer Center offers the IMPACT Program to help women navigate
ntimacy,
enopause, and
elvic Health
fter
ancer
reatment.
Capital Health Adds Pulsed Field Ablation System, Improving Access to Care for AFib Patients in Mercer and Bucks Counties
Specialists from Capital Health’s Cardiac Electrophysiology Program, part of its Heart and Vascular Institute, unveiled a new, minimally invasive pulsed field ablation system at the Al Maghazehe Heart and Vascular Center located at Capital Health Regional Medical Center (RMC). The addition of the new system doubles the hospital’s capacity to treat atrial fibrillation (AFib) patients who are candidates for ablation.
View All News
Preparing for Birth: Childbirth Education 4-Week Series
April 23, 2026 at 6:30PM
More Information
Preparing for Birth: Condensed Childbirth Education
April 25, 2026 at 9:30AM
More Information
Understanding Breastfeeding Class
April 28, 2026 at 4:00PM
More Information
View All Events